|  | Exposed workers | Non-exposed workers | ||
---|---|---|---|---|---|
 |  | N | % | N | % |
Sexb** | Male/Female | 107/25 | 81/19 | 55/59 | 48/52 |
Smoker | No+Former/Yes | 77/52 | 60/40 | 71/42 | 63/37 |
Atopy | Negative/Positive | 94/37 | 72/28 | 82/31 | 73/27 |
SYMPTOMS | Â | Â | Â | Â | Â |
Eye symptomsb** | No/Yes | 71/57 | 55/45 | 89/25 | 78/22 |
Wheeze etc. | No/Yes | 88/41 | 68/32 | 90/24 | 79/21 |
Dry coughb** | No/Yes | 88/39 | 69/31 | 101/13 | 89/11 |
Cough with mucus | No/Yes | 84/44 | 66/34 | 87/27 | 76/24 |
Nose bleedb** | No/Yes | 96/28 | 78/23 | 107/7 | 94/6 |
GENOTYPES/PHENOTYPES | Â | Â | Â | Â | Â |
GSTM1 | +/- | 65/67 | 49/51 | 65/49 | 57/43 |
GSTT1 | +/- | 110/22 | 83/17 | 97/17 | 85/15 |
GSTM3 | AA/AB/BB | 94/36/2 | 71/27/2 | 78/31/5 | 68/27/4 |
GSTP1* 105 | II/IV/VV | 68/51/13 | 52/39/10 | 57/46/11 | 50/40/10 |
GSTP1* 114 | AA/AV | 114/18 | 86/14 | 103/11 | 90/10 |
GSTP1* 105 +114 | A/B/C | 68/46/18 | 51/35/14 | 57/46/11 | 50/40/10 |
NAT1 phenotype | S/IM/R | 3/88/41 | 2/67/31 | 3/76/35 | 3/67/30 |
NAT2 phenotype | S/IM/R | 89/33/10 | 67/25/8 | 73/38/3 | 64/33/3 |
MPO b** | GG/GA/AA | 97/29/6 | 73/22/5 | 74/40/0 | 65/35/0 |
SULT1A1 | GG/GA/AA | 43/77/12 | 33/58/9 | 46/54/14 | 40/47/12 |
CYP1A1*2A | A/B/C | 116/14/2 | 88/11/2 | 97/16/1 | 85/14/1 |
CYP1A1*2B | AA/AG/GG | 126/5/1 | 95/4/1 | 107/7/0 | 94/6/0 |
TNF-308 | GG/GA/AA | 83/35/4 | 68/29/3 | 69/35/5 | 63/32/5 |
TNF-863 | CC/CA/AA | 93/28/6 | 73/22/5 | 78/32/2 | 70/29/2 |
CCL5 | GG/GA/AA | 84/38/5 | 66/30/4 | 72/36/4 | 64/32/4 |
HLA-DQB1*05 | -/+ | 88/39 | 69/31 | 87/25 | 78/22 |
HLA-DQB1*0501b* | -/+ | 98/29 | 77/23 | 98/14 | 88/12 |
HLA-DQB1*0502 | -/+ | 118/9 | 93/7 | 105/7 | 94/6 |
HLA-DQB1*0503 | -/+ | 125/2 | 98/2 | 108/4 | 96/4 |
HLA-DQB1*0504 | -/+ | 126/1 | 99/1 | 112/0 | 100/0 |